Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.

Annals of surgical oncology - 1 Dec 2014

Lin Li-Han, Lin Ming-Wei, Mar Kwei, Lin Chun-Shu, Ji Dar-Der, Lee Wei-Ping, Lee Herng-Sheng, Cheng Ming-Fang, Hsia Kan-Tai

Abstract excerpt

BACKGROUND: The aim of this study was to investigate the impact of hMLH1 polymorphisms on treatment outcomes in patients with oral squamous cell carcinoma (OSCC). METHODS: Genotypings were performed by direct DNA sequencing in peripheral blood leukocytes from 185 male OSCC patients. Patients received primary surgery with or without adjuvant radiotherapy. Two hMLH1 tag single nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Mouth Neoplasms

Share to MutL Protein Homolog 1

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Survival Rate

Source

Identifiers

PMID: 25047469
DOI: 10.1245/s10434-014-3897-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.PMID 25047469Read ↗

HMGB1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients.Semantic proximity Read ↗

MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.Semantic proximity Read ↗

Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.Semantic proximity Read ↗

The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.Semantic proximity Read ↗

The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.Semantic proximity Read ↗

Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.Semantic proximity Read ↗

Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.Semantic proximity Read ↗

A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.Semantic proximity Read ↗

The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis.Semantic proximity Read ↗

Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.Semantic proximity Read ↗

Does Hypoxia-Inducible Factor -1 α (HIF-1α) C1772T polymorphism predict short-term prognosis in patients with oral squamous cell carcinoma (OSCC)?Semantic proximity Read ↗

Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.